Abstract
Pneumonic plague, caused by Yersinia pestis, is characterized by bacterial evasion and manipulation of the mammalian innate immune system. Following an initial anti-inflammatory response to infection in the lung, bacteria grow rapidly accompanied by host cell death and a massive inflammatory response. Phagocytic cells, in particular macrophages, are targeted and eliminated by the bacterial type III secretion system. In this work, we discuss the mechanisms by which the type III secretion system regulates host cell death during pulmonary infection by Y. pestis. We focus on the role of effector Yops E, J and K in this process and how they coordinately regulate cell death mechanisms that lead to precise control over inflammation during infection.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Aili M, Hallberg B, Wolf-Watz H et al (2002) GAP activity of Yersinia YopE. Methods Enzymol 358:359–370
Aili M, Isaksson EL, Carlsson SE et al (2008) Regulation of Yersinia Yop-effector delivery by translocated YopE. Int J Med Microbiol 298:183–192. doi: S1438-4221(07)00086-0 [pii] 10.1016/j.ijmm.2007.04.007
Aktories K (2011) Bacterial protein toxins that modify host regulatory GTPases. Nat Rev Microbiol 9:487–498. doi: 10.1038/nrmicro2592 nrmicro2592 [pii]
Bergsbaken T, Cookson BT (2007) Macrophage activation redirects Yersinia-infected host cell death from apoptosis to caspase-1-dependent pyroptosis. PLoS Pathog 3:e161. doi: 07-PLPA-RA-0189 [pii] 10.1371/journal.ppat.0030161
Bergsbaken T, Cookson BT (2009) Innate immune response during Yersinia infection: critical modulation of cell death mechanisms through phagocyte activation. J Leukoc Biol 86:1153–1158. doi: jlb.0309146 [pii] 10.1189/jlb.0309146
Bliska JB (2000) Yop effectors of Yersinia spp. and actin rearrangements. Trends Microbiol 8:205–208. doi: S0966-842X(00)01738-8 [pii]
Brodsky IE, Medzhitov R (2008) Reduced secretion of YopJ by Yersinia limits in vivo cell death but enhances bacterial virulence. PLoS Pathog 4:e1000067. doi: 10.1371/journal.ppat.1000067
Brodsky IE, Palm NW, Sadanand S et al (2010) A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system. Cell Host Microbe 7:376–387. doi: S1931-3128(10)00139-3 [pii] 10.1016/j.chom.2010.04.009
Cornelis GR (2000) Molecular and cell biology aspects of plague. Proc Natl Acad Sci U S A 97:8778–8783. doi: 97/16/8778 [pii]
Dewoody R, Merritt PM, Houppert AS et al (2011) YopK regulates the Yersinia pestis type III secretion system from within host cells. Mol Microbiol 79:1445–1461. doi: 10.1111/j.1365-2958.2011.07534.x
Duprez L, Wirawan E, Vanden Berghe T et al (2009) Major cell death pathways at a glance. Microbes Infect 11:1050–1062. doi: S1286-4579(09)00204-4 [pii] 10.1016/j.micinf.2009.08.013
Dziarski R (2006) Deadly plague versus mild-mannered TLR4. Nat Immunol 7:1017–1019. doi: ni1006-1017 [pii] 10.1038/ni1006-1017
Fink SL, Cookson BT (2007) Pyroptosis and host cell death responses during Salmonella infection. Cell Microbiol 9:2562–2570. doi: CMI1036 [pii] 10.1111/j.1462-5822.2007.01036.x
Franchi L, Eigenbrod T, Munoz-Planillo R et al (2009) The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 10:241–247. doi: ni.1703 [pii] 10.1038/ni.1703
Garcia JT, Ferracci F, Jackson MW et al (2006) Measurement of effector protein injection by type III and type IV secretion systems by using a 13-residue phosphorylatable glycogen synthase kinase tag. Infect Immun 74:5645–5657. doi: 74/10/5645 [pii] 10.1128/IAI.00690-06
Grobner S, Schulz S, Soldanova I et al (2007) Absence of Toll-like receptor 4 signaling results in delayed Yersinia enterocolitica YopP-induced cell death of dendritic cells. Infect Immun 75:512–517. doi: IAI.00756-06 [pii] 10.1128/IAI.00756-06
Holmstrom A, Rosqvist R, Wolf-Watz H et al (1995) YopK, a novel virulence determinant of Yersinia pseudotuberculosis. Contrib Microbiol Immunol 13:239–243
Holmstrom A, Petterson J, Rosqvist R et al (1997) YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane. Mol Microbiol 24:73–91
Khare S, Luc N, Dorfleutner A, Stehlik C (2010) Inflammasomes and their activation. Crit Rev Immunol 30:463–487. doi: 76236f9f086f9f9f,533412001b624d4b [pii]
Lamkanfi M, Dixit VM (2011) Modulation of inflammasome pathways by bacterial and viral pathogens. J Immunol 187:597–602. doi: 187/2/597 [pii] 10.4049/jimmunol.1100229
Lemaitre N, Sebbane F, Long D, Hinnebusch BJ (2006) Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague. Infect Immun 74:5126–5131. doi: 74/9/5126 [pii] 10.1128/IAI.00219-06
Lilo S, Zheng Y, Bliska JB (2008) Caspase-1 activation in macrophages infected with Yersinia pestis KIM requires the type III secretion system effector YopJ. Infect Immun 76:3911–3923. doi: IAI.01695-07 [pii] 10.1128/IAI.01695-07
Lukaszewski RA, Kenny DJ, Taylor R et al (2005) Pathogenesis of Yersinia pestis infection in BALB/c mice: effects on host macrophages and neutrophils. Infect Immun 73:7142–7150. doi: 73/11/7142 [pii] 10.1128/IAI.73.11.7142-7150.2005
Mak TW, Yeh WC (2002) Signaling for survival and apoptosis in the immune system. Arthritis Res 4(Suppl 3):S243–S252
Marketon MM, DePaolo RW, DeBord KL et al (2005) Plague bacteria target immune cells during infection. Science 309:1739–1741. doi: 1114580 [pii] 10.1126/science.1114580
McIntire CR, Yeretssian G, Saleh M (2009) Inflammasomes in infection and inflammation. Apoptosis 14:522–535. doi: 10.1007/s10495-009-0312-3
Mejia E, Bliska JB, Viboud GI (2008) Yersinia controls type III effector delivery into host cells by modulating Rho activity. PLoS Pathog 4:e3. doi: 07-PLPA-RA-0173 [pii] 10.1371/journal.ppat.0040003
Monack DM, Mecsas J, Ghori N, Falkow S (1997) Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proc Natl Acad Sci U S A 94:10385–10390
Palmer LE, Hobbie S, Galan JE, Bliska JB (1998) YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNF-alpha production and downregulation of the MAP kinases p38 and JNK. Mol Microbiol 27:953–965
Reed LJ, Muench H (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27:493–497
Santic M, Pavokovic G, Jones S et al (2010) Regulation of apoptosis and anti-apoptosis signalling by Francisella tularensis. Microbes Infect 12:126–134. doi: S1286-4579(09)00242-1 [pii] 10.1016/j.micinf.2009.11.003
Schotte P, Denecker G, Van Den Broeke A et al (2004) Targeting Rac1 by the Yersinia effector protein YopE inhibits caspase-1-mediated maturation and release of interleukin-1beta. J Biol Chem 279:25134–25142. doi: 10.1074/jbc.M401245200 M401245200 [pii]
Schroder K, Tschopp J (2010) The inflammasomes. Cell 140:821–832. doi: S0092-8674(10)00075-9 [pii] 10.1016/j.cell.2010.01.040
Serrels B, Sandilands E, Frame MC (2011) Signaling of the direction-sensing FAK/RACK1/PDE4D5 complex to the small GTPase Rap1. Small Gtpases 2:54–61. doi: 10.4161/sgtp. 2.1.15137 2154-1248-2-1-11 [pii]
Thorslund SE, Edgren T, Pettersson J et al (2011) The RACK1 signaling scaffold protein selectively interacts with Yersinia pseudotuberculosis virulence function. PLoS One 6:e16784. doi: 10.1371/journal.pone.0016784
Viboud GI, Bliska JB (2001) A bacterial type III secretion system inhibits actin polymerization to prevent pore formation in host cell membranes. EMBO J 20:5373–5382. doi: 10.1093/emboj/20.19.5373
Viboud GI, Mejia E, Bliska JB (2006) Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection. Cell Microbiol 8:1504–1515. doi: CMI729 [pii] 10.1111/j.1462-5822.2006.00729.x
Witzenrath M, Pache F, Lorenz D et al (2011) The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia. J Immunol 187:434–440. doi: jimmunol.1003143 [pii] 10.4049/jimmunol.1003143
Wolke S, Ackermann N, Heesemann J (2011) The Yersinia enterocolitica type 3 secretion system (T3SS) as toolbox for studying the cell biological effects of bacterial Rho GTPase modulating T3SS effector proteins. Cell Microbiol. doi: 10.1111/j.1462-5822.2011.01623.x
Wong KW, Isberg RR (2005) Yersinia pseudotuberculosis spatially controls activation and misregulation of host cell Rac1. PLoS Pathog 1:e16. doi: 10.1371/journal.ppat.0010016
Zauberman A, Cohen S, Mamroud E et al (2006) Interaction of Yersinia pestis with macrophages: limitations in YopJ-dependent apoptosis. Infect Immun 74:3239–3250. doi: 74/6/3239 [pii] 10.1128/IAI.00097-06
Zheng Y, Lilo S, Brodsky IE et al (2011) A Yersinia effector with enhanced inhibitory activity on the NF-kappaB pathway activates the NLRP3/ASC/caspase-1 inflammasome in macrophages. PLoS Pathog 7:e1002026. doi: 10.1371/journal.ppat.1002026
Zumbihl R, Aepfelbacher M, Andor A et al (1999) The cytotoxin YopT of Yersinia enterocolitica induces modification and cellular redistribution of the small GTP-binding protein RhoA. J Biol Chem 274:29289–29293
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media New York
About this paper
Cite this paper
Peters, K.N., Anderson, D.M. (2012). Modulation of Host Cell Death Pathways by Yersinia Species and the Type III Effector YopK. In: de Almeida, A., Leal, N. (eds) Advances in Yersinia Research. Advances in Experimental Medicine and Biology, vol 954. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3561-7_29
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3561-7_29
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-3560-0
Online ISBN: 978-1-4614-3561-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)